Literature DB >> 6302135

Transferrin receptors in human tissues: their distribution and possible clinical relevance.

K C Gatter, G Brown, I S Trowbridge, R E Woolston, D Y Mason.   

Abstract

The distribution of transferrin receptors (TR) has been studied in a range of normal and malignant tissues using four monoclonal antibodies, BK19.9, B3/25, T56/14 and T58/1. In normal tissues TR was found in a limited number of sites, notably basal epidermis, the endocrine pancreas, hepatocytes, Kupffer cells, testis and pituitary. This restricted pattern of distribution may be relevant to the characteristic pattern of iron deposition in primary haemachromatosis. In contrast to this limited pattern of expression in normal tissue, the receptor was widely distributed in carcinomas, sarcomas and in samples from cases of Hodgkin's disease. This malignancy-associated expression of the receptor may play a role in the anaemia of advanced malignancy by competing with the bone marrow for serum iron.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302135      PMCID: PMC498283          DOI: 10.1136/jcp.36.5.539

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Isolation and characterization of the transferrin receptor from human placenta.

Authors:  P A Seligman; R B Schleicher; R H Allen
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

2.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

3.  An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumours.

Authors:  M E Bramwell; H Harris
Journal:  Proc R Soc Lond B Biol Sci       Date:  1978-04-13

4.  Serum transferrin and ceruloplasmin concentrations in patients with carcinoma, melanoma, sarcoma and cancers of haematopoietic tissues.

Authors:  N R Hughes
Journal:  Aust J Exp Biol Med Sci       Date:  1972-02

5.  Erythropoietic insufficiency in mice with extramedullary tumor.

Authors:  R L DeGowin; F M Grund; D P Gibson
Journal:  Blood       Date:  1978-01       Impact factor: 22.113

6.  Transferrin receptor in human placental brush border membranes. Studies on the binding of transferrin to placental membrane vesicles and the identification of a placental brush border glycoprotein with high affinity for transferrin.

Authors:  H G Wada; P E Hass; H H Sussman
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

7.  Host-tumor interactions: basis for the anemia in rats bearing the hepatoma 7777.

Authors:  C Lamar; A S Greene; W B Greene
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

8.  Transferrin and transferrin receptors in carcinoma of the breast.

Authors:  W P Faulk; B L Hsi; P J Stevens
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

9.  Human cell-surface glycoprotein with unusual properties.

Authors:  M B Omary; I S Trowbridge; J Minowada
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

10.  Novel surface antigen expressed on dividing cells but absent from nondividing cells.

Authors:  W Judd; C A Poodry; J L Strominger
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  137 in total

1.  Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.

Authors:  Marc Cinci; Srinivas Mamidi; Wenhan Li; Volker Fehring; Michael Kirschfink
Journal:  Target Oncol       Date:  2014-11-15       Impact factor: 4.493

2.  An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.

Authors:  Patrick P Ng; Jay S Dela Cruz; David N Sorour; James M Stinebaugh; Seung-Uon Shin; Daniel S Shin; Sherie L Morrison; Manuel L Penichet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 3.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 4.  Proliferation indices in malignant lymphomas.

Authors:  J Crocker
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

5.  Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cells.

Authors:  Ronak Talati; Andrew Vanderpoel; Amina Eladdadi; Kate Anderson; Ken Abe; Margarida Barroso
Journal:  Methods       Date:  2013-08-28       Impact factor: 3.608

6.  Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.

Authors:  Rick K Huang; Nicole F Steinmetz; Chi-Yu Fu; Marianne Manchester; John E Johnson
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

7.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

8.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

9.  Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.

Authors:  Bruna Dos Santos Rodrigues; Hiroshi Oue; Amrita Banerjee; Takahisa Kanekiyo; Jagdish Singh
Journal:  J Control Release       Date:  2018-07-31       Impact factor: 9.776

Review 10.  Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.

Authors:  Darren Lars Stirland; Joseph W Nichols; Seiji Miura; You Han Bae
Journal:  J Control Release       Date:  2013-10-02       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.